论文部分内容阅读
我院自1990年1月~1992年12月,共收治92例食道癌患者,全部经组织学检查证实。现报告其中资料较完整的67例有关的临床资料,并分析讨论。 67例中术后分为,单纯化疗16例,合并化疗、放疗51例,其化疗方案为:CBDCA(卡铂)400~500mg/m~2,静脉输入,第一天。MMC(丝裂霉素)20~40mg/静脉输入第一天。5FU(5肤脲嘧啶)750mg静脉输入1~3天。PyM(平阳要素)10mg肌肉注射,2次/周,连用4周,一般均进行2~4个周期。
In our hospital from January 1990 to December 1992, a total of 92 patients with esophageal cancer were treated and all were confirmed by histological examination. 67 cases of clinical data with relatively complete information are reported and analyzed and discussed. Ninety-seven patients were divided into two groups: chemotherapy alone, chemotherapy alone and radiotherapy (n = 51). The chemotherapy regimen was: CBDCA (carboplatin) 400-500 mg/m2, intravenous infusion, on the first day. MMC (mitomycin) 20 to 40 mg/intravenous was input on the first day. 5FU (5 uracil) 750 mg intravenous input 1 to 3 days. PyM (pingyang factor) 10mg intramuscular injection, 2 times / week, once every 4 weeks, generally 2 to 4 cycles.